Molloy AM - Search Results

1

Evaluation of transcobalamin II polymorphisms as neural tube defect risk factors in an Irish population.

Swanson DA, Pangilinan F, Mills JL, Kirke PN, Conley M, Weiler A, Frey T, Parle-McDermott A, O'Leary VB, Seltzer RR, Moynihan KA, Molloy AM, Burke H, Scott JM, Brody LC. Swanson DA, et al. Among authors: molloy am. Birth Defects Res A Clin Mol Teratol. 2005 Apr;73(4):239-44. doi: 10.1002/bdra.20122. Birth Defects Res A Clin Mol Teratol. 2005. PMID: 15782407

2

Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects.

Molloy AM, Kirke P, Hillary I, Weir DG, Scott JM. Molloy AM, et al. Arch Dis Child. 1985 Jul;60(7):660-5. doi: 10.1136/adc.60.7.660. Arch Dis Child. 1985. PMID: 4026363 Free PMC article.

3

Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects.

Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Kirke PN, et al. Among authors: molloy am. Q J Med. 1993 Nov;86(11):703-8. Q J Med. 1993. PMID: 8265769

4

A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects.

Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. Whitehead AS, et al. Among authors: molloy am. QJM. 1995 Nov;88(11):763-6. QJM. 1995. PMID: 8542260

5

Homocysteine and neural tube defects.

Mills JL, Scott JM, Kirke PN, McPartlin JM, Conley MR, Weir DG, Molloy AM, Lee YJ. Mills JL, et al. Among authors: molloy am. J Nutr. 1996 Mar;126(3):756S-760S. doi: 10.1093/jn/126.suppl_3.756S. J Nutr. 1996. PMID: 8598561 Review.

6

Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations.

Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott JM. Molloy AM, et al. Lancet. 1997 May 31;349(9065):1591-3. doi: 10.1016/S0140-6736(96)12049-3. Lancet. 1997. PMID: 9174561

7

Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method.

Molloy AM, Scott JM. Molloy AM, et al. Methods Enzymol. 1997;281:43-53. doi: 10.1016/s0076-6879(97)81007-5. Methods Enzymol. 1997. PMID: 9250965 No abstract available.

8

Minimum effective dose of folic acid for food fortification to prevent neural-tube defects.

Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, Weir DG, Scott JM. Daly S, et al. Among authors: molloy am. Lancet. 1997 Dec 6;350(9092):1666-9. doi: 10.1016/S0140-6736(97)07247-4. Lancet. 1997. PMID: 9400511 Clinical Trial.

9

Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays.

Molloy AM, Mills JL, Kirke PN, Whitehead AS, Weir DG, Scott JM. Molloy AM, et al. Clin Chem. 1998 Jan;44(1):186-8. Clin Chem. 1998. PMID: 9550581 No abstract available.

10

Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor.

Molloy AM, Mills JL, Kirke PN, Ramsbottom D, McPartlin JM, Burke H, Conley M, Whitehead AS, Weir DG, Scott JM. Molloy AM, et al. Am J Med Genet. 1998 Jun 30;78(2):155-9. Am J Med Genet. 1998. PMID: 9674907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page